When Symptoms Overlap, Clarity Matters
When an unclear diagnosis for severe cases demands fast, actionable answers, the BIOFIRE® Respiratory 2.1 (RP2.1) Panels offers broad coverage with our upper respiratory test, which identifies up to 23 targets in about 45 minutes. Compared to the current standard of care, syndromic testing successfully identifies pathogens over 57% more frequently.1
Help Guide Pneumonia Treatment with Greater Confidence
The wrong antibiotic decision can have real consequences for critically ill pneumonia patients, and the right diagnostic insights can make all the difference in quickly delivering appropriate therapy. Compared to current standard-of-care testing, the BIOFIRE® FILMARRAY® Pneumonia (PN) Panels helped 20.6% more HAP/VAP patients receive optimized therapy within the first 24 hours.2
Respiratory and Sore Throat Results without the Wait
Advancing diagnostic stewardship during respiratory season with the right level of insight adapted to patient’s condition and clinical context. Because hospitalizations account for most respiratory episode costs, testing patients at-risk of complication for up to 15 targets in ~15 minutes, may offer greater clinical and economic advantages over low-plex and/or laboratory-based PCR approaches by supporting earlier management decisions and helping prevent costly care escalation.3

Turn Diagnostic Data into Actionable Insights
Get more out of your diagnostic data than individual test results. BIOFIRE® FIREWORKS™ transforms diagnostic data from BIOFIRE® Systems into operational and epidemiological insights, helping healthcare organizations improve efficiency, optimize resources, and support informed decision-making across their network.
FAST RESPIRATORY TESTING FOR EVERY CARE SETTING.
Whether you're treating patients in hospital beds, outpatient clinics, or critical care departments, BIOFIRE® syndromic testing solutions offer the fast, accurate answers you need to improve outcomes and streamline care.
Video Title 2
Video description 2.
Video Title 3
Video description 3.
Earlier Answers. More Confident Respiratory Care.
References
- Kitano T. J Infect Chemother. 2020;26(1):82–85.
- Enne V.I., et al. (2025) Intensive Care Med.
- Werbrouck A, et al. Value Health. 2024. doi:10.1016/j.jval.2024.10.2481.
